Rekvina Laboratories Limited (BOM:526075)
India · Delayed Price · Currency is INR 39.14
+1.86 (4.99%)
At close: Aug 17, 2026
Rekvina Laboratories Market Cap
Rekvina Laboratories has a market cap or net worth of 235.94 million as of August 18, 2026. Its market cap has increased by 769.78% in one year.
Market Cap
235.94M
Enterprise Value
250.51M
Revenue
19.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.14
ChartMarket Cap Chart
Since July 26, 2013, Rekvina Laboratories's market cap has decreased from 443.60M to 235.94M, a decrease of -46.81%. That is a compound annual growth rate of -4.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 235.94M | 769.78% |
| Dec 13, 2021 | 27.13M | 4.65% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Panjon | 327.67M |
| Walpar Nutritions | 327.26M |
| Deccan Health Care | 306.64M |
| Gujarat Terce Laboratories | 301.52M |
| Welcure Drugs and Pharmaceuticals | 296.63M |
| Cian Healthcare | 238.75M |
| Hamps Bio | 213.44M |
| Colinz Laboratories | 201.20M |